All Articles

New research reveals 89% of crypto buyers demand fee transparency. As platforms obscure costs, one firm's push for clarity could reshape the entire industry.

The Swiss platform announced 500k users, but our analysis reveals a complex picture of its market position, regulatory standing, and true scale.

The distributor's dual listing on NYSE Texas is more than a formality. It's a calculated bet on a new financial center and a signal for savvy investors.

UpGuard's Google Cloud debut isn't just a new listing; it's a signal of a major shift in how security is bought, managed, and operationalized.

Minnesota unveils its new pro volleyball team, the Forge. Backed by powerhouse owners and a booming league, the franchise is a strategic bet on women's sports.

A new composition of matter patent extends protection for Alterity's lead drug to 2045, de-risking its path in MSA and opening a new front against Parkinson's.

Beyond the headline, Stanley Black & Decker's billion-dollar investment is a blueprint for tackling the skilled labor crisis and reshoring America's future.

A key leadership transition at Atlanta's airport CID and MARTA isn't just a personnel shuffle; it's a strategic realignment of power players shaping the region.

Generation Mining's early cost wins on its Marathon project are promising, but with 70% of capital yet to be bid, is this a true de-risking event?

With revenue up 23%, Rubicon Organics invests heavily in new facility tech, temporarily squeezing profits to fuel its bid for long-term global dominance.

A new AI agent from Assort Health is automating the chaotic patient referral process, promising to recover lost revenue and get patients to care faster.

AI firm Darrow's 250% growth lands it on the Inc. 5000, signaling a major shift in how AI is used to predict and manage multi-billion dollar legal risks.

The partnership between Gridiron Capital and vdB&A isn't just a deal; it's a signal that operational outsourcing is now a core pillar of life sciences innovation.

Early data for Sutro Biopharma's STRO-004 offers a glimmer of hope for advanced cancer patients. We look at the tech, the trials, and the financial tightrope.

Magna5's fourth consecutive Inc. 5000 ranking is celebrated, but the real story is a blueprint for survival and growth in a volatile digital economy.

Breast cancer survivor and marketing powerhouse Amber Guild takes the helm at Susan G. Komen, bringing a potent blend of personal insight and corporate strategy.

With breakthrough dialysis data and a new heart-mending vessel, Humacyte is balancing radical innovation with commercial reality. Is this the future of medicine?

As Firehouse Subs opens its 1,500th store, we analyze its unique model blending franchisee success, a $115M mission, and RBI's strategic backing.

A new partnership aims to bring the first FDA-approved, oral ketamine pill for depression to your home, using AI and real-world data to ensure safety.

Beyond a vibrant tribute to Kashmir's culture, Asian Paints' new art initiatives are a masterclass in brand strategy amid rising competition. Here's the real story.